MX2012001024A - Composicion de preparaciones externas para la piel. - Google Patents
Composicion de preparaciones externas para la piel.Info
- Publication number
- MX2012001024A MX2012001024A MX2012001024A MX2012001024A MX2012001024A MX 2012001024 A MX2012001024 A MX 2012001024A MX 2012001024 A MX2012001024 A MX 2012001024A MX 2012001024 A MX2012001024 A MX 2012001024A MX 2012001024 A MX2012001024 A MX 2012001024A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- dermatitis
- effective
- patients
- external preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- 201000004624 Dermatitis Diseases 0.000 abstract 3
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 abstract 2
- 102000012421 C-Type Natriuretic Peptide Human genes 0.000 abstract 2
- 101800000060 C-type natriuretic peptide Proteins 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 230000037307 sensitive skin Effects 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009172589 | 2009-07-23 | ||
| JP2010134600 | 2010-06-11 | ||
| PCT/JP2010/062459 WO2011010732A1 (ja) | 2009-07-23 | 2010-07-23 | 皮膚外用剤組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012001024A true MX2012001024A (es) | 2012-04-11 |
Family
ID=43499204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012001024A MX2012001024A (es) | 2009-07-23 | 2010-07-23 | Composicion de preparaciones externas para la piel. |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20120208756A1 (OSRAM) |
| EP (1) | EP2457581B1 (OSRAM) |
| JP (5) | JP4834190B2 (OSRAM) |
| KR (2) | KR101226165B1 (OSRAM) |
| CN (4) | CN110339346B (OSRAM) |
| AU (1) | AU2010274293B9 (OSRAM) |
| BR (1) | BR112012001491B1 (OSRAM) |
| CA (1) | CA2768810C (OSRAM) |
| DK (1) | DK2457581T3 (OSRAM) |
| ES (1) | ES2456502T3 (OSRAM) |
| MX (1) | MX2012001024A (OSRAM) |
| NZ (1) | NZ597797A (OSRAM) |
| RU (2) | RU2572694C2 (OSRAM) |
| WO (1) | WO2011010732A1 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101226165B1 (ko) * | 2009-07-23 | 2013-01-24 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
| EP2666475B1 (en) | 2011-01-21 | 2017-08-16 | Igisu Co., Ltd. | Therapeutic agent for alopecia |
| ES2488740B1 (es) * | 2012-10-10 | 2015-06-11 | J. Álvaro GALIANO RAMOS | Formulación cosmética y dermatologica para el alivio del prurito |
| CN104367925A (zh) * | 2014-11-07 | 2015-02-25 | 济南高达信息技术有限公司 | 一种治疗红皮病的中药洗剂及其制备方法 |
| US12221495B2 (en) * | 2015-05-29 | 2025-02-11 | Igisu Co., Ltd. | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide |
| KR102132544B1 (ko) * | 2015-06-19 | 2020-07-09 | 글로벌 헬스 솔루션즈, 엘엘씨 | 활성 성분들을 위한 페트롤라툼-계 전달 시스템 |
| CA2994091A1 (en) * | 2015-07-31 | 2017-02-09 | Igisu Co., Ltd. | A cnp cyclic peptide and a medicament, external preparation and cosmetic comprising the cyclic peptide |
| CN105617360B (zh) * | 2015-12-04 | 2018-12-21 | 中国农业大学 | C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用 |
| WO2017192923A1 (en) * | 2016-05-05 | 2017-11-09 | Monosol Rx, Llc | Pharmaceutical compositions with enhanced permeation |
| KR20230137362A (ko) | 2016-05-05 | 2023-10-04 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
| EP3515470B1 (en) * | 2016-09-21 | 2023-06-14 | Agency for Science, Technology and Research | Methods for predicting skin inflammation and determining cancer susceptibility |
| JP7125862B2 (ja) * | 2018-05-29 | 2022-08-25 | 小林製薬株式会社 | 外用組成物 |
| JP2019214520A (ja) * | 2018-06-12 | 2019-12-19 | 花王株式会社 | 角層剥離改善剤 |
| CN110302194B (zh) * | 2019-07-23 | 2023-01-31 | 广州市皮肤病防治所(广州市性病防治监测中心) | 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂 |
| US11419917B2 (en) | 2020-04-07 | 2022-08-23 | Drora Shevy | Treatment for SARS-CoV-2 and other coronaviruses |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
| JP7466939B2 (ja) * | 2022-08-31 | 2024-04-15 | 東洋ビューティ株式会社 | Ｏ／ｄ相組成物及び水中油型乳化組成物 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114923A (en) | 1988-05-31 | 1992-05-19 | California Biotechnology Inc. | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| JP2809533B2 (ja) * | 1991-01-31 | 1998-10-08 | 壽之 松尾 | Ｃｎｐ類似体ペプチド |
| JPH05207891A (ja) | 1991-03-08 | 1993-08-20 | Shionogi & Co Ltd | 脳性ナトリウム利尿ペプチドの製造方法 |
| WO1994020534A1 (en) | 1993-03-03 | 1994-09-15 | Mayo Foundation For Medical Education And Research | Vasonatrin peptide and analogs thereof |
| US6028055A (en) | 1996-10-22 | 2000-02-22 | Genetech, Inc. | Receptor selective BNP |
| US5965533A (en) | 1997-05-23 | 1999-10-12 | Baxter International Inc. | Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions |
| JP3799465B2 (ja) | 1998-09-28 | 2006-07-19 | 参天製薬株式会社 | ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤 |
| US6833358B1 (en) | 1998-09-28 | 2004-12-21 | Santen Pharmaceutical Co., Ltd. | Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides |
| US6407211B1 (en) * | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| IL142118A0 (en) | 2001-03-20 | 2002-03-10 | Prochon Biotech Ltd | Method and composition for treatment of skeletal dysplasias |
| JP3676707B2 (ja) * | 2001-07-18 | 2005-07-27 | 三菱電機株式会社 | 車両用交流発電機の固定子およびその製造方法 |
| WO2004022003A2 (en) | 2002-09-06 | 2004-03-18 | University Of South Florida | Materials and methods for treatment of allergic diseases |
| US20050271596A1 (en) | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
| US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
| DE60331584D1 (de) | 2002-11-26 | 2010-04-15 | Biocon Ltd | Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen |
| US20040161435A1 (en) * | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
| EP1637162A4 (en) | 2003-06-13 | 2009-07-15 | Asubio Pharma Co Ltd | MEDICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF IMMUNOLOGICAL ILLNESSES TH1 TYPE |
| EP1638443B1 (en) * | 2003-06-20 | 2010-10-20 | Mayo Foundation For Medical Education And Research | Isoforms of brain natriuretic peptide |
| JP2007525213A (ja) | 2004-01-27 | 2007-09-06 | コンピュゲン ユーエスエイ，インク． | 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 |
| AU2005207886A1 (en) | 2004-01-27 | 2005-08-11 | Compugen Usa, Inc. | Novel brain natriuretic peptide variants and methods of use thereof |
| EP3620530A1 (en) | 2004-03-31 | 2020-03-11 | Kazuwa Nakao | Composition for increasing body height |
| ES2465141T3 (es) | 2004-03-31 | 2014-06-05 | Kazuwa Nakao | Remedio o medicamento preventivo para la artritis |
| JP2008509746A (ja) | 2004-08-11 | 2008-04-03 | アルザ・コーポレーシヨン | ナトリウム利尿ペプチドを経皮送達する器具および方法 |
| DE102004048576A1 (de) * | 2004-10-04 | 2006-04-13 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Methode zur Bräunung der Haut |
| EP1810716A1 (de) * | 2005-12-23 | 2007-07-25 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Verfahren zur Bräunung der Haut |
| TW200817431A (en) | 2006-08-08 | 2008-04-16 | Mayo Foundation | Diuretic and natriuretic polypeptides |
| JPWO2008032450A1 (ja) | 2006-09-15 | 2010-01-21 | 国立大学法人京都大学 | 脂肪肝の予防剤および／または治療剤 |
| US20120034183A1 (en) | 2006-12-19 | 2012-02-09 | Michael Cohen | Compositions and methods for growing embryonic stem cells |
| JP5010913B2 (ja) | 2006-12-31 | 2012-08-29 | 寿子 小出 | 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法 |
| JP2010168283A (ja) | 2007-04-24 | 2010-08-05 | Yamaguchi Univ | ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤 |
| WO2008140125A1 (ja) | 2007-05-10 | 2008-11-20 | National University Corporation Nagoya University | 腹膜線維化抑制用医薬組成物 |
| KR20100056517A (ko) * | 2007-09-11 | 2010-05-27 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드의 용도 |
| KR20100057641A (ko) * | 2007-09-11 | 2010-05-31 | 몬도바이오테크 래보래토리즈 아게 | 인터메딘 ４７ 및 ５３ 펩티드의 치료적 용도 |
| AR069409A1 (es) * | 2007-11-21 | 2010-01-20 | Biomarin Pharm Inc | Variantes de peptidos natriureticos de tipo c |
| DK2307447T3 (da) | 2008-07-02 | 2016-06-20 | Mayo Foundation | Natriuretiske polypeptider med unikke farmakologiske profiler |
| WO2010048308A2 (en) * | 2008-10-24 | 2010-04-29 | Deborah Dickey | Natriuretic polypeptides |
| US8150603B2 (en) | 2008-11-26 | 2012-04-03 | Caterpillar Inc. | Engine control system having fuel-based timing |
| WO2010078325A2 (en) | 2008-12-29 | 2010-07-08 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides for reducing or preventing restenosis |
| HRP20161739T1 (hr) * | 2009-05-20 | 2017-03-10 | Biomarin Pharmaceutical Inc. | VARIJANTE NATRIURETIČNOG PEPTIDA C-tipa |
| KR101226165B1 (ko) | 2009-07-23 | 2013-01-24 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
| JP2011024973A (ja) * | 2009-07-24 | 2011-02-10 | Mitsumasa Maeda | 電子ペーパー付き便蓋 |
| RU2502519C2 (ru) | 2009-08-27 | 2013-12-27 | Кёко ЭНДО | Терапевтическое средство для лечения ринита |
| ITPG20090061A1 (it) | 2009-11-27 | 2011-05-28 | Andrea Marcantonini | Impianto mobile per la produzione di calcestruzzo |
| EP2666475B1 (en) | 2011-01-21 | 2017-08-16 | Igisu Co., Ltd. | Therapeutic agent for alopecia |
-
2010
- 2010-07-23 KR KR1020117017629A patent/KR101226165B1/ko active Active
- 2010-07-23 DK DK10802352.4T patent/DK2457581T3/da active
- 2010-07-23 CA CA2768810A patent/CA2768810C/en active Active
- 2010-07-23 ES ES10802352.4T patent/ES2456502T3/es active Active
- 2010-07-23 CN CN201910657053.3A patent/CN110339346B/zh active Active
- 2010-07-23 AU AU2010274293A patent/AU2010274293B9/en active Active
- 2010-07-23 US US13/386,528 patent/US20120208756A1/en not_active Abandoned
- 2010-07-23 CN CN201410324381.9A patent/CN104189893B/zh active Active
- 2010-07-23 CN CN201080032443.9A patent/CN102470163B/zh active Active
- 2010-07-23 JP JP2011507738A patent/JP4834190B2/ja active Active
- 2010-07-23 EP EP10802352.4A patent/EP2457581B1/en active Active
- 2010-07-23 KR KR1020127027521A patent/KR101533695B1/ko active Active
- 2010-07-23 RU RU2012103653/15A patent/RU2572694C2/ru active
- 2010-07-23 WO PCT/JP2010/062459 patent/WO2011010732A1/ja not_active Ceased
- 2010-07-23 MX MX2012001024A patent/MX2012001024A/es active IP Right Grant
- 2010-07-23 NZ NZ597797A patent/NZ597797A/xx unknown
- 2010-07-23 BR BR112012001491-9A patent/BR112012001491B1/pt active IP Right Grant
- 2010-07-23 CN CN201610329663.7A patent/CN105999230B/zh active Active
-
2011
- 2011-02-18 JP JP2011033976A patent/JP5778440B2/ja active Active
-
2013
- 2013-09-03 US US14/016,637 patent/US9358269B2/en active Active
-
2015
- 2015-07-09 JP JP2015137445A patent/JP6055518B2/ja active Active
-
2016
- 2016-01-22 RU RU2015150099A patent/RU2015150099A/ru not_active Application Discontinuation
- 2016-05-06 US US15/148,470 patent/US9968654B2/en active Active
- 2016-12-02 JP JP2016234905A patent/JP6337071B2/ja active Active
-
2017
- 2017-12-11 US US15/837,964 patent/US10946072B2/en active Active
-
2018
- 2018-05-07 JP JP2018089006A patent/JP2018135381A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012001024A (es) | Composicion de preparaciones externas para la piel. | |
| WO2011017274A3 (en) | Compositions for promoting a healthy appearance of the skin | |
| WO2017155232A3 (ko) | 발모 촉진 활성 및/또는 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도 | |
| WO2017164609A3 (ko) | 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도 | |
| EP2490700A4 (en) | EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF | |
| WO2012116990A3 (en) | Novel use | |
| PH12019502874A1 (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
| AR117730A1 (es) | Composición para relajación muscular | |
| CN104586657A (zh) | 保湿护手霜 | |
| Draelos | The effect of a combination of recombinant EGF cosmetic serum and a crosslinked hyaluronic acid serum as compared to a fibroblast-conditioned media serum on the appearance of aging skin | |
| CN105362105A (zh) | 一种改善肌肤新陈代谢并能延缓衰老的面膜及其制备方法 | |
| WO2011051948A3 (en) | Hair care compositions and materials | |
| WO2014091146A3 (fr) | Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant | |
| CN104586711A (zh) | 滋润护手霜 | |
| SG11201909144VA (en) | Bacterial secretome for use in the treatment of skin lesions | |
| MX2016008546A (es) | Reduccion de queloides utilizando alantoina topica. | |
| WO2021101128A3 (en) | Fine bubble-containing cosmetic for improving dermal penetration, manufacturing system of fine bubble-containing cosmetic for improving dermal penetration, and manufacturing method of fine bubble-containing cosmetic for improving dermal penetration | |
| CN104586712A (zh) | 美白护手霜 | |
| WO2014091147A3 (fr) | Utilisation cosmetique de l'association d'un extrait de germe de caroube et de cafeine en tant qu'agent actif amincissant | |
| WO2010142957A3 (en) | Uses of mannose-6-phosphate | |
| WO2012140609A3 (en) | System for prolonged release of cosmetic agents | |
| MX2019014426A (es) | Composicion farmaceutica para usarse en la mejora de la calidad del cuero cabelludo y la piel, de la cicatrizacion de heridas o mejora de la calidad del cabello. | |
| CN106727208A (zh) | 唇膏 | |
| MX2022001707A (es) | Composicion cosmetica topica, uso de la composicion y tonico para aplicacion facial. | |
| US20180221258A1 (en) | Microdelivery triple acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |